DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes
Fadimana Kaya, Findlay Bewicke‐Copley, Juho Jalmari Miettinen…·Ana Rio‐Machín
This study identifies DEK::NUP214 as an XPO1-dependent transcriptional activator of leukemia genes, showing selective response to XPO1 inhibitors in t(6;9) AML cases.